SQSTM1 and Parkinson disease: In this subacute MPTP mice model, dabrafenib did not affect the expression of other proteins such as α-synuclein, p62, glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (IBA-1), which are known to be associated with the pathophysiology of PD (Supplementary Material, Fig. S3C).